Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer.
Crit Rev Oncog. 2019;24(2):199-212. doi: 10.1615/CritRevOncog.2019031641.
Crit Rev Oncog. 2019.
PMID: 31679214
Review.